The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: Additional analysis from the Japan Diabetes Complications Study

被引：56

作者：

Sone, H

Tanaka, S

Ishibashi, S

Yamasaki, Y

Oikawa, S

Ito, H

Saito, Y

Ohashi, Y

Akanuma, Y

Yamada, N

机构：

[1] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan

[2] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Stat & Canc Control Div, Tokyo, Japan

[3] Jichi Med Coll, Dept Endocrinol & Metab, Minami Kawachi, Tochigi, Japan

[4] Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Osaka, Japan

[5] Nippon Med Coll, Dept Med, Tokyo 113, Japan

[6] Tama Hokubu Med Ctr, Tokyo, Japan

[7] Chiba Univ, Grad Sch Med, Dept Internal Med, Chiba, Japan

[8] Univ Tokyo, Dept Biostat Epidemiol & Prevent Hlth Sci, Tokyo, Japan

[9] Inst Adult Dis, Asahi Life Fdn, Tokyo, Japan

来源：

DIABETES CARE | 2006年 / 29卷 / 01期

关键词：

D O I：

10.2337/diacare.29.01.06.dc05-1341

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：145 / 147

页数：3

共 19 条

[1]

[Anonymous], 2005, IDF CONS WORLDW DEF

[2] The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study [J].

Bonora, E ;

Targher, G ;

Formentini, G ;

Calcaterra, F ;

Lombardi, S ;

Marini, F ;

Zenari, L ;

Saggiani, F ;

Poli, M ;

Perbellini, S ;

Raffaelli, A ;

Gemma, L ;

Santi, L ;

Bonadonna, RC ;

Muggeo, M .

DIABETIC MEDICINE, 2004, 21 (01) :52-58

[3] Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 3 diabetes [J].

Bruno, G ;

Merletti, F ;

Biggeri, A ;

Bargero, G ;

Ferrero, S ;

Runzo, C ;

Cerai, SP ;

Pagano, G ;

Cavallo-Perin, P .

DIABETES CARE, 2004, 27 (11) :2689-2694

[4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[5] Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence [J].

Ford, ES .

DIABETES CARE, 2005, 28 (07) :1769-1778

[6]

Gavin JR, 1997, DIABETES CARE, V20, P1183

[7] Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].

Isomaa, B ;

Almgren, P ;

Tuomi, T ;

Forsén, B ;

Lahti, K ;

Nissén, M ;

Taskinen, MR ;

Groop, L .

DIABETES CARE, 2001, 24 (04) :683-689

[8] The metabolic syndrome - is one global definition possible? [J].

Jorgensen, ME ;

Borch-Johnsen, K .

DIABETIC MEDICINE, 2004, 21 (10) :1064-1065

[9] Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese multi-provincial cohort study [J].

Liu, J ;

Hong, YL ;

D'Agostino, RB ;

Wu, ZS ;

Wang, W ;

Sun, JY ;

Wilson, PWF ;

Kannel, WB ;

Zhao, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (21) :2591-2599

[10] Asia's big problem [J].

Mandavilli, A ;

Cyranoski, D .

NATURE MEDICINE, 2004, 10 (04) :325-327

← 1 2 →